ASHP
  • Program
  • Registration
  • ASHP Spotlight
  • Midyear Coverage
  • Awards and Events
  • ASHP Marketplace
  • Meeting Info
  • Previews
Topics
  • ASHP Spotlight
  • Midyear Coverage
  • Awards and Events
  • ASHP Marketplace
  • Meeting Info
  • Previews
Resources
  • Program
  • Registration
Facebook iconTwitter iconLinkedIn iconInstagram icon
October 27, 2021

Experts Expect the Unexpected: Checking in on Checkpoint Inhibitors and Immune-Related Adverse Events


From left: Jordan McPherson and Tonya Smith
From left: Jordan McPherson and Tonya Smith

The immune checkpoint inhibitors (ICIs), which modulate the immune system to induce or potentiate its anti-tumor activity, have dramatically changed the landscape of cancer treatment by shifting the focus of therapy from the tumor itself to the host’s immune system. However, ICI therapy is not without drawbacks, including the potential for immune-related adverse events (irAEs), some of which are potentially life-threatening.

Join us for this Virtual Midday Symposium where Jordan McPherson, oncology clinical pharmacist, Huntsman Cancer Institute and adjunct assistant professor, University of Utah College of Pharmacy, Salt Lake City, Utah and Tonya Smith, clinical pharmacy specialist, internal medicine, Emory University Hospital Midtown, Atlanta, Georgia, will examine the unique mechanisms of actions of ICIs and associated irAEs that can result during cancer treatment.

The incredible clinical success of immune checkpoint inhibitors has resulted in widespread use across many cancer types. The indications for use continue to expand at a rapid pace and the development of novel immune checkpoint inhibitors and combination therapies continue to be evaluated for multiple indications. Observations and reports of toxicities, sometimes severe, have been described in nearly every organ system. These irAEs manifest differently depending on the pathway targeted by the therapy (i.e., CTLA-4 or PD-1/PD-L1), and the emerging use of combination therapies has only increased the frequency of adverse events.

Learners will take away recommendations for best practices for the prevention and management of irAEs, including patient education, recognition, treatment, and monitoring.

This 1.5-hour virtual Midday Symposium, A Proactive, Patient-Centered Approach to the Managing Immune-Related Adverse Events takes place on Thursday, Dec. 9 from 1 to 2:30 p.m. ET and is accredited for continuing pharmacy education. Register now at www.ashpadvantage.com/manageirae and explore the full initiative which includes podcasts, live and enduring webinars, and faculty commentaries.

This activity is provided by ASHP and supported by an independent medical education grant from Merck, Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme.

Featured Stories
Geospatial Tools Offer Fresh Perspective on Patient Care
Sponsored by ASHP
Geospatial Tools Offer Fresh Perspective on Patient Care
ASHP announces new Leadership Center and Membership Group
Sponsored by ASHP
ASHP announces new Leadership Center and Membership Group
More Content
Close Up Hand Holding Covid 19 Vaccine 2021 08 28 03 48 08 Utc
ASHP Midyear 2021
FDA, CDC Experts Share COVID-19 Vaccine Progress
December 8, 2021
Thomas Lodise and Michael Rybak
ASHP Midyear 2021
Trough Levels Don’t Cut It for Vancomycin Dosing in Seriously Ill Patients
December 8, 2021
Getty Images 1344197992
ASHP Midyear 2021
Anti-Racism and Its Role in Achieving Health Equity
December 8, 2021
Getty Images 638044582
ASHP Midyear 2021
Don’t Get Caught Sleeping on 340B, Experts Say
December 8, 2021
Cyrine Haidar and Shannon Manzi
ASHP Midyear 2021
Pharmacogenomic Testing Can Benefit Children and Families
December 8, 2021
Brenda Jensen and Jerald Ovesen
ASHP Midyear 2021
Big Changes Coming From USP and NIOSH
December 8, 2021
Tyler Vest
ASHP Midyear 2021
New Research Brings Changes to the Medication-Use Process
December 8, 2021
Terri Jorgenson and Lisa Kearney
ASHP Midyear 2021
An All Hands on Deck Approach for Mental Health and Pain Care
December 8, 2021
Cheyenne Frazier and Karen Gunning
ASHP Midyear 2021
Transgender Care Is Patient Care
December 8, 2021
From left: Andre D. Harvin, Patricia C. Kienle, and Clinton L. Meachum
ASHP Midyear 2021
Thursday’s Virtual Midday Symposia
December 8, 2021
Getty Images 1313783716
ASHP Midyear 2021
Highlights from 10th Annual Pharmacy Forecast Unveiled at Midyear
December 7, 2021
Jao Tribute Mdn
ASHP Midyear 2021
Remembering Joseph A. Oddis, a Giant in Pharmacy
December 7, 2021
ASHP
Facebook iconTwitter iconLinkedIn iconInstagram icon
© 2023 Ascend Media. All rights reserved.